API change not reported during WHO PQ assessment – preventing PQ suspension


Published on 29/01/2026

Preventing Suspension from WHO PQ Due to Unreported API Changes

In today’s complex pharmaceutical landscape, companies face the daunting challenge of maintaining compliance with regulatory bodies while managing changes in Active Pharmaceutical Ingredients (API). A common scenario arises when an API change is not reported during the World Health Organization (WHO) Prequalification (PQ) assessment, potentially leading to a PQ suspension. This article serves as a critical playbook for pharma professionals looking to navigate this intricate situation.

For deeper guidance and related home-care methods, check this WHO Prequalification (PQ).

By following the actionable strategies outlined herein, you will be equipped to identify signals on the floor or in the lab, investigate thoroughly, and implement effective corrective actions. This will not only aid in maintaining compliance with WHO and other regulatory bodies such as the FDA, EMA, and MHRA but also enhance your audit readiness and overall Quality Management System (QMS).

Symptoms/Signals on the Floor or

in the Lab

Recognizing the early symptoms of potential compliance issues regarding API changes is crucial for timely intervention. These symptoms often manifest as:

  • Product Performance Variability: Inconsistent quality or unexpected test results during stability studies or batch analysis.
  • Increased Deviations: A noticeable rise in deviation reports related to production or quality control processes.
  • Regulatory Queries: Receiving inquiries from regulatory bodies about your APIs without prior disclosure of changes.
  • Documentation Anomalies: Inconsistencies between batch records and submitted regulatory documentation.

Being vigilant about these signals can help your organization take immediate steps to address the underlying issues before they escalate into significant compliance threats.

Likely Causes

To understand why APIs changes might go unreported during WHO PQ assessments, we can categorize the likely causes into the following groups:

1. Materials

Changes in raw materials or suppliers can occur without proper documentation or risk assessments, affecting API consistency and quality.

2. Method

Changes in manufacturing methods that may have been overlooked or not documented adequately lead to discrepancies in the final product.

3. Machine

Equipment upgrades or replacements that change operating parameters must be documented, or variability can arise from unreported conditions.

4. Man (Personnel)

Staff turnover or inadequate training on change control procedures can lead to non-compliance.

5. Measurement

Improper calibration of analytical instruments may result in incorrect data that do not accurately reflect introduced changes.

6. Environment

Changes in manufacturing conditions (temperature, humidity) that affect API quality need to be monitored closely.

Understanding these categories can help pinpoint root causes during investigations, allowing for more targeted corrective actions.

Immediate Containment Actions (First 60 Minutes)

Once symptoms of unreported API changes are detected, swift containment is critical. Here are the immediate actions to undertake within the first hour:

  1. Cease Production: Halt any production runs that may be impacted by the unreported API change.
  2. Notify Key Stakeholders: Alert leadership, quality assurance, and regulatory compliance teams.
  3. Review Documentation: Gather all relevant documentation related to recent API changes for initial assessment.
  4. Implement Temporary Controls: Enforce additional monitoring of production processes and quality controls until a root cause analysis can be conducted.

These actions bolster your compliance stance and demonstrate an organizational commitment to maintaining quality standards.

Investigation Workflow

An effective investigation workflow helps to ensure that the issue is thoroughly analyzed and remedial actions are derived from solid evidence. The following steps outline this process:

  1. Data Collection: Systematically gather data from quality control records, batch production records, and deviation logs.
  2. Contextual Analysis: Review the timing and nature of the API changes, correlating them with any deviations or quality-related issues.
  3. Stakeholder Interviews: Conduct interviews with relevant personnel to assess knowledge of the API changes and associated controls.
  4. Trend Analysis: Utilize statistical process control (SPC) tools to look for trends in quality data over time.

This structured investigation approach will facilitate the identification of root causes while also preparing the organization for potential regulatory scrutiny.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Utilizing the appropriate root cause analysis (RCA) tools enhances the efficacy of your investigations:

1. 5-Why Analysis

This simple iterative questioning technique explores the cause-and-effect chain. It is best used for straightforward problems with known variables.

2. Fishbone Diagram

A visual tool that categorizes potential causes into predefined groups, making it useful for more complex situations where multiple factors contribute to an issue.

3. Fault Tree Analysis

This diagrammatic method breaks down the failure into various pathways, useful for understanding interactions in a more complex process than the previous methods can address.

Related Reads

Selecting the right tool depends on the complexity of the issue at hand and the available data. Utilizing these tools effectively ensures a comprehensive understanding of any failures within your processes.

CAPA Strategy (Correction, Corrective Action, Preventive Action)

Once the root causes have been identified, a robust Corrective and Preventive Action (CAPA) strategy must be implemented:

1. Correction

This involves immediate actions to address the non-compliance, e.g., repealing the affected batches or correcting batch records.

2. Corrective Action

Long-term solutions should be formulated based on root cause findings, such as revising training programs or improving documentation practices.

3. Preventive Action

Implement systemic changes to prevent recurrence, which may include more rigorous change control procedures or enhanced material tracking systems.

Documenting all CAPA actions is vital not only for internal quality audits but also for potential regulatory inspections.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

Implementing a robust control strategy is essential for ongoing compliance. Below are the key elements of an effective monitoring program:

  • Statistical Process Control (SPC): Regularly analyze the variations in quality parameters to detect anomalies early.
  • Trending: Use software tools to visualize trends in batch performances over time.
  • Sampling: Enhance sampling protocols to ensure that representative samples reflect any API changes.
  • Alarms: Establish automatic alerts for deviations outside acceptable limits.
  • Verification: Regularly audit controls to confirm ongoing compliance with WHO GMP guidelines.

Constant vigilance in these areas ensures that your manufacturing processes remain within compliance and that potential issues can be addressed proactively.

Validation / Re-qualification / Change Control Impact (When Needed)

Changes in API require careful consideration of validation, re-qualification, and change control protocols:

  • Validation: If changes significantly affect the API or manufacturing process, comprehensive validation may be necessary.
  • Re-qualification: Systems and equipment used in the manufacturing of the API must be re-qualified post-change to verify their operational reliability.
  • Change Control: All changes must undergo a formally documented change control process to ensure compliance with regulatory expectations.

These steps ensure that any modifications do not undermine product quality or regulatory compliance and can facilitate future inspections.

Inspection Readiness: What Evidence to Show

When it comes to inspections by authorities such as the FDA, EMA, or MHRA, being prepared with appropriate documentation is essential. Ensure you have the following:

  • Records: Comprehensive batch production records reflecting any changes made.
  • Logs: Deviations logs documenting any quality-related issues associated with the API changes.
  • Batch Documents: Original and revised validation documents that outline the API changes and their rationale.
  • Deviation Reports: Well-documented reports that demonstrate your investigation and CAPA processes.

Having organized records readily accessible proves your commitment to compliance and quality assurance during inspections.

FAQs

What should I do if an API change is discovered post-PQ submission?

Immediately inform relevant stakeholders and initiate a deviation report, then investigate as per your quality procedures.

How can we ensure staff are trained on change control processes?

Regular training sessions and updates during team meetings can enhance awareness and adherence to change control protocols.

What are the consequences of not reporting an API change?

Failure to report API changes can lead to regulatory non-compliance, potentially resulting in product recalls, penalties, or suspension of PQ status.

How frequently should I review change control procedures?

Change control procedures should be reviewed at least annually or when significant changes in operations occur.

What are key elements for effective monitoring of QR processes?

Effective monitoring includes SPC, regular audits, proper documentation, and ongoing staff training.

Is deviation reporting mandatory?

Yes, deviation reporting is a critical aspect of compliance as it helps to identify and rectify non-conformities in the production process.

What happens during a regulatory inspection?

During a regulatory inspection, inspectors will review documentation, audit processes, and may observe production operations to assess compliance.

What steps can we take to improve our preparedness for an inspection?

Regular internal audits, staff training, and maintaining organized records can significantly enhance your preparedness for inspections.

Pharma Tip:  CAPA effectiveness doubted during inspection preparation – preventing PQ suspension